87 related articles for article (PubMed ID: 16490314)
1. Characterization of the neuronal dopamine transporter DAT in human blood platelets.
Frankhauser P; Grimmer Y; Bugert P; Deuschle M; Schmidt M; Schloss P
Neurosci Lett; 2006 May; 399(3):197-201. PubMed ID: 16490314
[TBL] [Abstract][Full Text] [Related]
2. Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter.
Zhao G; Li S; Qin GW; Fei J; Guo LH
J Ethnopharmacol; 2007 Jul; 112(3):498-506. PubMed ID: 17555897
[TBL] [Abstract][Full Text] [Related]
3. Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner.
Pifl C; Wolf A; Rebernik P; Reither H; Berger ML
Neuropharmacology; 2009 Feb; 56(2):531-40. PubMed ID: 19000913
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of neuronal dopamine and serotonin transporters DAT and SERT in megakaryocytes and platelets generated from human MEG-01 megakaryoblasts.
Hohmann S; Schweinfurth N; Lau T; Deuschle M; Lederbogen F; Banaschewski T; Schloss P
Cell Tissue Res; 2011 Nov; 346(2):151-61. PubMed ID: 22006250
[TBL] [Abstract][Full Text] [Related]
5. A pincer-like configuration of TM2 in the human dopamine transporter is responsible for indirect effects on cocaine binding.
Sen N; Shi L; Beuming T; Weinstein H; Javitch JA
Neuropharmacology; 2005 Nov; 49(6):780-90. PubMed ID: 16216288
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of dopamine transporter by iron chelation in vitro is mediated by altered trafficking, not synthesis.
Wiesinger JA; Buwen JP; Cifelli CJ; Unger EL; Jones BC; Beard JL
J Neurochem; 2007 Jan; 100(1):167-79. PubMed ID: 17227437
[TBL] [Abstract][Full Text] [Related]
7. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
8. The dopamine transporter proteome.
Torres GE
J Neurochem; 2006 Apr; 97 Suppl 1():3-10. PubMed ID: 16635244
[TBL] [Abstract][Full Text] [Related]
9. Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells.
Chen N; Reith ME
J Neurochem; 2007 Apr; 101(2):377-88. PubMed ID: 17250655
[TBL] [Abstract][Full Text] [Related]
10. A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking.
Nass R; Hahn MK; Jessen T; McDonald PW; Carvelli L; Blakely RD
J Neurochem; 2005 Aug; 94(3):774-85. PubMed ID: 15992384
[TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter inhibitory and antiparkinsonian effect of common flowering quince extract.
Zhao G; Jiang ZH; Zheng XW; Zang SY; Guo LH
Pharmacol Biochem Behav; 2008 Sep; 90(3):363-71. PubMed ID: 18485464
[TBL] [Abstract][Full Text] [Related]
12. Candidate gene studies of attention-deficit/hyperactivity disorder.
Faraone SV; Khan SA
J Clin Psychiatry; 2006; 67 Suppl 8():13-20. PubMed ID: 16961425
[TBL] [Abstract][Full Text] [Related]
13. Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors.
Loland CJ; Desai RI; Zou MF; Cao J; Grundt P; Gerstbrein K; Sitte HH; Newman AH; Katz JL; Gether U
Mol Pharmacol; 2008 Mar; 73(3):813-23. PubMed ID: 17978168
[TBL] [Abstract][Full Text] [Related]
14. Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities.
Lin Z; Uhl GR
Pharmacogenomics J; 2003; 3(3):159-68. PubMed ID: 12815364
[TBL] [Abstract][Full Text] [Related]
15. Dopamine transporter immunoreactive terminals in the bovine pineal gland.
Phansuwan-Pujito P; Boontem P; Chetsawang B; Ebadi M; Govitrapong P
Neurosci Lett; 2006 Jul; 403(1-2):78-83. PubMed ID: 16781060
[TBL] [Abstract][Full Text] [Related]
16. Gain of function mutants reveal sites important for the interaction of the atypical inhibitors benztropine and bupropion with monoamine transporters.
Mortensen OV; Amara SG
J Neurochem; 2006 Sep; 98(5):1531-40. PubMed ID: 16923164
[TBL] [Abstract][Full Text] [Related]
17. Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells.
Wang J; Michelhaugh SK; Bannon MJ
Eur J Neurosci; 2007 Apr; 25(7):1982-6. PubMed ID: 17439486
[TBL] [Abstract][Full Text] [Related]
18. GABA and glutamate transporters are expressed in human platelets.
Rainesalo S; Keränen T; Saransaari P; Honkaniemi J
Brain Res Mol Brain Res; 2005 Nov; 141(2):161-5. PubMed ID: 16198020
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression and capacity of the striatal high-affinity choline transporter in hyperdopaminergic mice.
Parikh V; Apparsundaram S; Kozak R; Richards JB; Sarter M
Neuroscience; 2006 Aug; 141(1):379-89. PubMed ID: 16675138
[TBL] [Abstract][Full Text] [Related]
20. Regulation of dopamine and MPP+ transport by catecholamine transporters.
Dohi T; Kitayama S; Morioka N; Kumagai K; Mitsuhata C; Morita K; Kozai K; Lin Z; Uhl GR
Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):43-7. PubMed ID: 15164608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
